A cocktail of humanized anti–pertussis toxin antibodies limits disease in murine and baboon models of whooping cough

Tetanus and diphtheria toxoids and acellular pertussis vaccine uptake during pregnancy in a metropolitan tertiary care center

(2015) C. Mary Healy et al.   VACCINE

TheBordetellaAdenylate Cyclase Repeat-in-Toxin (RTX) Domain Is Immunodominant and Elicits Neutralizing Antibodies

(2014) Xianzhe Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Maternal and Neonatal Vaccination Protects Newborn Baboons From Pertussis Infection

(2014) Jason M. Warfel et al.   JOURNAL OF INFECTIOUS DISEASES

Different Effects of Whole-Cell and Acellular Vaccines on Bordetella Transmission

(2014) William E. Smallridge et al.   JOURNAL OF INFECTIOUS DISEASES

The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels – A prospective study

(2014) Bahaa Abu Raya et al.   VACCINE

A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, Motavizumab-YTE, Has an Extended Half-Life in Healthy Adults

(2013) Gabriel J. Robbie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Exchange Blood Transfusion In The Management Of Severe Pertussis In Young Infants

(2013) Delma Nieves et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

(2013) J. M. Warfel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults—A review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience

(2013) Birgit Thierry-Carstensen et al.   VACCINE

Pertussis: Challenges Today and for the Future

(2013) James D. Cherry   PLoS Pathogens

Nonhuman Primate Model of Pertussis

(2012) Jason M. Warfel et al.   INFECTION AND IMMUNITY

Airborne Transmission of Bordetella pertussis

(2012) J. M. Warfel et al.   JOURNAL OF INFECTIOUS DISEASES

Antibody nanoparticle dispersions formed with mixtures of crowding molecules retain activity and In Vivo bioavailability

(2012) Maria A. Miller et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Attenuated Bordetella pertussis Vaccine Candidate BPZE1 Promotes Human Dendritic Cell CCL21-Induced Migration and Drives a Th1/Th17 Response

(2011) G. Fedele et al.   JOURNAL OF IMMUNOLOGY

BM-ca is a newly defined type I/II anti-CD20 monoclonal antibody with unique biological properties

(2010) Nishida   INTERNATIONAL JOURNAL OF ONCOLOGY

Global, regional, and national causes of child mortality in 2008: a systematic analysis

(2010) Robert E Black et al.   LANCET

Characterization of a Key Neutralizing Epitope on Pertussis Toxin Recognized by Monoclonal Antibody 1B7

(2009) Jamie N. Sutherland et al.   BIOCHEMISTRY

Pertussis Vaccine

(2009) John B. Robbins et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Bordetella pertussis Infection or Vaccination Substantially Protects Mice against B. bronchiseptica Infection

(2009) Elizabeth M. Goebel et al.   PLoS One

Pathology and Pathogenesis of FatalBordetella pertussisInfection in Infants

(2008) Christopher D. Paddock et al.   CLINICAL INFECTIOUS DISEASES

Pertussis Toxin Inhibits Early Chemokine Production To Delay Neutrophil Recruitment in Response to Bordetella pertussis Respiratory Tract Infection in Mice

(2008) C. Andreasen et al.   INFECTION AND IMMUNITY